4/15/2024NHC Issues the Guidelines for the Diagnosis and Treatment of Primary L...

4/15/2024China Biopharma Tracker – Q1 2024 (PharmaDJ)

4/15/2024The Pharmaceutical Playbook for Asia’s Private Market (PharmExec)

4/12/2024Whooping Cough Resurges in Post-Pandemic China

4/12/2024PhIIC: Review of Chinese Hospital Drug Market in 2023

4/12/2024Review of Chinese Online Pharmacy Drug Sales and Leading Products in 2...

4/12/2024Recent Executive Moves

4/12/2024Drug R&D and Product Registration News Digest April 2024 (2)

4/11/2024CDE Issues the Summary of Bioequivalence Studies for Generic Drugs

4/11/2024NHSA's 2023 Healthcare Security Sector Development Statistical Highlig...

4/11/2024NHSA Disputes Claims of a 'Dropout Wave' in China's Basic Medical Insu...

4/11/2024Out-of-Area Medical Bill Settlement Jumps Nearly Fourfold After BMI S...

4/11/2024Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...

4/11/2024Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...

4/10/2024Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...

4/10/2024Generic Drugs Has Experienced Falling Market Share Since 2018

4/10/2024Review of Class 1 New Drug R&D in China 2018-2023

4/9/2024Broad Measures Outlined at the 2024 Natl Conference on Rectifying Viol...

4/9/2024Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023

4/9/2024CEO Podcast: Hengrui's US Subsidiary's CEO, CMO On Chinese Pharma Goin...

4/8/2024Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...

4/8/2024Over 11M Chinese Residents Benefited from Major Disease Insurance in 2...

4/8/2024NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules

4/5/2024Ascletis Drops FXR Agonist ASC42 After Disappointing Phase II Results

4/5/2024China Continues to Crackdown on Monopoly and Unfair Market Practices i...

4/5/2024UB and 7th Affiliated Hospital of SYU Launch A Joint Clinical Research...

4/5/2024Drug R&D and Product Registration News Digest April 2024 (1)

4/5/2024Recent Official Changes and Executive Moves

4/5/2024Foreign Investors Fled Chinese Biotech After the Pandemic. They Still ...

4/4/2024Rohto and Mitsui to Buy TCM Company for $590M

Page:11/718 Total number of articles:21530: [First][<<] [9] [10] [11] [12] [13] [>>] [End]